Search

everythinglearnresearchcommunity

for

Search:↓

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Overweight women with PCOS are more likely to have excess male hormones.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

High androgen levels in young women with PCOS are linked to higher blood pressure.

PCOS is linked to low-grade chronic inflammation.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Lower SHBG levels may increase the risk of PCOS.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.